Profusa (NVACW) Long-Term Debt Repayments (2025 - 2026)

Profusa (NVACW) reported Long-Term Debt Repayments of $441000.0 for Q1 2026, down 75.94% quarter-over-quarter from $1.8 million in Q4 2025.

Profusa (NVACW) Long-Term Debt Repayments (2025 - 2026) Analysis & Trends

Profusa has reported Long-Term Debt Repayments for 2 years, with the latest figure at $441000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Repayments (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	1.42 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	1.00 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Profusa	-	-	-	441,000.00

Download Data